Pharmaceuticals

Global Mitomycin C Market Professional Survey Report 2018

  • QYR2636346
  • 109 Pages
  • July 2018
  • Pharmaceuticals
Download Sample    Get Discount   
 
This report studies the global Mitomycin C market status and forecast, categorizes the global Mitomycin C market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).

Mitomycin C market, Mitomycin C is an antibiotic which acts as a double-stranded DNA alkylating agent. It covalently crosslinks DNA, inhibiting DNA synthesis and cell proliferation It acts by way of reductive activation either through low pH or NAD(P)H:quinone oxidoreductase (DT-diaphorase) or NADH cytochrome c reductase (Mao et al.; Cummings et al.).

In the last several years, Global market of Mitomycin C was experienced an upward trend rapidly, with an average growth rate of 4.76%. In 2016, Global Revenue of Mitomycin C is nearly 119.83 M USD; the actual production is about 17370 K Unit.

The global average price of Mitomycin C is in the increasing trend, from 6.30 USD/Unit in 2012 to 6.90 USD/Unit in 2016. With the situation of global economy, prices will be in increasing trend in the following five years.

The classification of Mitomycin C includes 2 Mg, 10 Mg, 40 Mg, and others. The proportion of 2 Mg in 2016 is about 41.5%, and the proportion is in decreasing trend from 2012 to 2016.

Mitomycin C is widely used in Cancer Treatment, Ophthalmic Use, and other field. The most proportion of Mitomycin C is Cancer Treatment, and the proportion in 2016 is 69%. The trend of Cancer Treatment is decreasing.

Japan is the largest supplier of Mitomycin C, with a production market share nearly 26.5% in 2016. India is the second largest supplier of Mitomycin C Media, enjoying production market share nearly 25% in 2016.

North America is the largest consumption place, with a consumption market share nearly 36% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 32.6%.

Market competition is not intense. Kyowa-kirin, Intas Pharmaceuticals, Teva, Bristol-Myers Squibb, Aspen, Speciality European Pharma, etc. are the leaders of the industry.

The global Mitomycin C market is valued at 120 million US$ in 2017 and will reach 100 million US$ by the end of 2025, growing at a CAGR of -2.2% during 2018-2025.

The major manufacturers covered in this report

Kyowa-kirin

Intas Pharmaceuticals

Teva

Bristol-Myers Squibb

Aspen

Speciality European Pharma

Alkem Laboratories

Varifarma

APOGEPHA

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering

North America

Europe

China

Japan

India

Southeast Asia

Other regions (Central & South America, Middle East & Africa)

We can also provide the customized separate regional or country-level reports, for the following regions:

North America

United States

Canada

Mexico

Asia-Pacific

China

India

Japan

South Korea

Australia

Indonesia

Singapore

Rest of Asia-Pacific

Europe

Germany

France

UK

Italy

Spain

Russia

Rest of Europe

Central & South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Saudi Arabia

Turkey

Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

2 Mg

10 Mg

40 Mg

Other

By Application, the market can be split into

Cancer Treatment

Ophthalmic Use

Others

The study objectives of this report are:

To analyze and study the global Mitomycin C capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);

Focuses on the key Mitomycin C manufacturers, to study the capacity, production, value, market share and development plans in future.

Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.

To define, describe and forecast the market by type, application and region.

To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

To identify significant trends and factors driving or inhibiting the market growth.

To analyze the opportunities in the market for stakeholders by identifying the high growth segments.

To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Mitomycin C are as follows:

History Year: 2013-2017

Base Year: 2017

Estimated Year: 2018

Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

Mitomycin C Manufacturers

Mitomycin C Distributors/Traders/Wholesalers

Mitomycin C Subcomponent Manufacturers

Industry Association

Downstream Vendors

Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:

Regional and country-level analysis of the Mitomycin C market, by end-use.

Detailed analysis and profiles of additional market players.

Table of Contents

Global Mitomycin C Market Professional Survey Report 2018

1 Industry Overview of Mitomycin C

1.1 Definition and Specifications of Mitomycin C

1.1.1 Definition of Mitomycin C

1.1.2 Specifications of Mitomycin C

1.2 Classification of Mitomycin C

1.2.1 2 Mg

1.2.2 10 Mg

1.2.3 40 Mg

1.2.4 Other

1.3 Applications of Mitomycin C

1.3.1 Cancer Treatment

1.3.2 Ophthalmic Use

1.3.3 Others

1.4 Market Segment by Regions

1.4.1 North America

1.4.2 Europe

1.4.3 China

1.4.4 Japan

1.4.5 Southeast Asia

1.4.6 India

2 Manufacturing Cost Structure Analysis of Mitomycin C

2.1 Raw Material and Suppliers

2.2 Manufacturing Cost Structure Analysis of Mitomycin C

2.3 Manufacturing Process Analysis of Mitomycin C

2.4 Industry Chain Structure of Mitomycin C

3 Technical Data and Manufacturing Plants Analysis of Mitomycin C

3.1 Capacity and Commercial Production Date of Global Mitomycin C Major Manufacturers in 2017

3.2 Manufacturing Plants Distribution of Global Mitomycin C Major Manufacturers in 2017

3.3 R&D Status and Technology Source of Global Mitomycin C Major Manufacturers in 2017

3.4 Raw Materials Sources Analysis of Global Mitomycin C Major Manufacturers in 2017

4 Global Mitomycin C Overall Market Overview

4.1 2013-2018E Overall Market Analysis

4.2 Capacity Analysis

4.2.1 2013-2018E Global Mitomycin C Capacity and Growth Rate Analysis

4.2.2 2017 Mitomycin C Capacity Analysis (Company Segment)

4.3 Sales Analysis

4.3.1 2013-2018E Global Mitomycin C Sales and Growth Rate Analysis

4.3.2 2017 Mitomycin C Sales Analysis (Company Segment)

4.4 Sales Price Analysis

4.4.1 2013-2018E Global Mitomycin C Sales Price

4.4.2 2017 Mitomycin C Sales Price Analysis (Company Segment)

5 Mitomycin C Regional Market Analysis

5.1 North America Mitomycin C Market Analysis

5.1.1 North America Mitomycin C Market Overview

5.1.2 North America 2013-2018E Mitomycin C Local Supply, Import, Export, Local Consumption Analysis

5.1.3 North America 2013-2018E Mitomycin C Sales Price Analysis

5.1.4 North America 2017 Mitomycin C Market Share Analysis

5.2 Europe Mitomycin C Market Analysis

5.2.1 Europe Mitomycin C Market Overview

5.2.2 Europe 2013-2018E Mitomycin C Local Supply, Import, Export, Local Consumption Analysis

5.2.3 Europe 2013-2018E Mitomycin C Sales Price Analysis

5.2.4 Europe 2017 Mitomycin C Market Share Analysis

5.3 China Mitomycin C Market Analysis

5.3.1 China Mitomycin C Market Overview

5.3.2 China 2013-2018E Mitomycin C Local Supply, Import, Export, Local Consumption Analysis

5.3.3 China 2013-2018E Mitomycin C Sales Price Analysis

5.3.4 China 2017 Mitomycin C Market Share Analysis

5.4 Japan Mitomycin C Market Analysis

5.4.1 Japan Mitomycin C Market Overview

5.4.2 Japan 2013-2018E Mitomycin C Local Supply, Import, Export, Local Consumption Analysis

5.4.3 Japan 2013-2018E Mitomycin C Sales Price Analysis

5.4.4 Japan 2017 Mitomycin C Market Share Analysis

5.5 Southeast Asia Mitomycin C Market Analysis

5.5.1 Southeast Asia Mitomycin C Market Overview

5.5.2 Southeast Asia 2013-2018E Mitomycin C Local Supply, Import, Export, Local Consumption Analysis

5.5.3 Southeast Asia 2013-2018E Mitomycin C Sales Price Analysis

5.5.4 Southeast Asia 2017 Mitomycin C Market Share Analysis

5.6 India Mitomycin C Market Analysis

5.6.1 India Mitomycin C Market Overview

5.6.2 India 2013-2018E Mitomycin C Local Supply, Import, Export, Local Consumption Analysis

5.6.3 India 2013-2018E Mitomycin C Sales Price Analysis

5.6.4 India 2017 Mitomycin C Market Share Analysis

6 Global 2013-2018E Mitomycin C Segment Market Analysis (by Type)

6.1 Global 2013-2018E Mitomycin C Sales by Type

6.2 Different Types of Mitomycin C Product Interview Price Analysis

6.3 Different Types of Mitomycin C Product Driving Factors Analysis

6.3.1 2 Mg Growth Driving Factor Analysis

6.3.2 10 Mg Growth Driving Factor Analysis

6.3.3 40 Mg Growth Driving Factor Analysis

6.3.4 Other Growth Driving Factor Analysis

7 Global 2013-2018E Mitomycin C Segment Market Analysis (by Application)

7.1 Global 2013-2018E Mitomycin C Consumption by Application

7.2 Different Application of Mitomycin C Product Interview Price Analysis

7.3 Different Application of Mitomycin C Product Driving Factors Analysis

7.3.1 Cancer Treatment of Mitomycin C Growth Driving Factor Analysis

7.3.2 Ophthalmic Use of Mitomycin C Growth Driving Factor Analysis

7.3.3 Others of Mitomycin C Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Mitomycin C

8.1 Kyowa-kirin

8.1.1 Company Profile

8.1.2 Product Picture and Specifications

8.1.2.1 Product A

8.1.2.2 Product B

8.1.3 Kyowa-kirin 2017 Mitomycin C Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.1.4 Kyowa-kirin 2017 Mitomycin C Business Region Distribution Analysis

8.2 Intas Pharmaceuticals

8.2.1 Company Profile

8.2.2 Product Picture and Specifications

8.2.2.1 Product A

8.2.2.2 Product B

8.2.3 Intas Pharmaceuticals 2017 Mitomycin C Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.2.4 Intas Pharmaceuticals 2017 Mitomycin C Business Region Distribution Analysis

8.3 Teva

8.3.1 Company Profile

8.3.2 Product Picture and Specifications

8.3.2.1 Product A

8.3.2.2 Product B

8.3.3 Teva 2017 Mitomycin C Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.3.4 Teva 2017 Mitomycin C Business Region Distribution Analysis

8.4 Bristol-Myers Squibb

8.4.1 Company Profile

8.4.2 Product Picture and Specifications

8.4.2.1 Product A

8.4.2.2 Product B

8.4.3 Bristol-Myers Squibb 2017 Mitomycin C Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.4.4 Bristol-Myers Squibb 2017 Mitomycin C Business Region Distribution Analysis

8.5 Aspen

8.5.1 Company Profile

8.5.2 Product Picture and Specifications

8.5.2.1 Product A

8.5.2.2 Product B

8.5.3 Aspen 2017 Mitomycin C Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.5.4 Aspen 2017 Mitomycin C Business Region Distribution Analysis

8.6 Speciality European Pharma

8.6.1 Company Profile

8.6.2 Product Picture and Specifications

8.6.2.1 Product A

8.6.2.2 Product B

8.6.3 Speciality European Pharma 2017 Mitomycin C Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.6.4 Speciality European Pharma 2017 Mitomycin C Business Region Distribution Analysis

8.7 Alkem Laboratories

8.7.1 Company Profile

8.7.2 Product Picture and Specifications

8.7.2.1 Product A

8.7.2.2 Product B

8.7.3 Alkem Laboratories 2017 Mitomycin C Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.7.4 Alkem Laboratories 2017 Mitomycin C Business Region Distribution Analysis

8.8 Varifarma

8.8.1 Company Profile

8.8.2 Product Picture and Specifications

8.8.2.1 Product A

8.8.2.2 Product B

8.8.3 Varifarma 2017 Mitomycin C Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.8.4 Varifarma 2017 Mitomycin C Business Region Distribution Analysis

8.9 APOGEPHA

8.9.1 Company Profile

8.9.2 Product Picture and Specifications

8.9.2.1 Product A

8.9.2.2 Product B

8.9.3 APOGEPHA 2017 Mitomycin C Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.9.4 APOGEPHA 2017 Mitomycin C Business Region Distribution Analysis

9 Development Trend of Analysis of Mitomycin C Market

9.1 Global Mitomycin C Market Trend Analysis

9.1.1 Global 2018-2025 Mitomycin C Market Size (Volume and Value) Forecast

9.1.2 Global 2018-2025 Mitomycin C Sales Price Forecast

9.2 Mitomycin C Regional Market Trend

9.2.1 North America 2018-2025 Mitomycin C Consumption Forecast

9.2.2 Europe 2018-2025 Mitomycin C Consumption Forecast

9.2.3 China 2018-2025 Mitomycin C Consumption Forecast

9.2.4 Japan 2018-2025 Mitomycin C Consumption Forecast

9.2.5 Southeast Asia 2018-2025 Mitomycin C Consumption Forecast

9.2.6 India 2018-2025 Mitomycin C Consumption Forecast

9.3 Mitomycin C Market Trend (Product Type)

9.4 Mitomycin C Market Trend (Application)

10 Mitomycin C Marketing Type Analysis

10.1 Mitomycin C Regional Marketing Type Analysis

10.2 Mitomycin C International Trade Type Analysis

10.3 Traders or Distributors with Contact Information of Mitomycin C by Region

10.4 Mitomycin C Supply Chain Analysis

11 Consumers Analysis of Mitomycin C

11.1 Consumer 1 Analysis

11.2 Consumer 2 Analysis

11.3 Consumer 3 Analysis

11.4 Consumer 4 Analysis

12 Conclusion of the Global Mitomycin C Market Professional Survey Report 2017

Methodology

Analyst Introduction

Data Source

List of Tables and Figures

Figure Picture of Mitomycin C

Table Product Specifications of Mitomycin C

Table Classification of Mitomycin C

Figure Global Production Market Share of Mitomycin C by Type in 2017

Figure 2 Mg Picture

Table Major Manufacturers of 2 Mg

Figure 10 Mg Picture

Table Major Manufacturers of 10 Mg

Figure 40 Mg Picture

Table Major Manufacturers of 40 Mg

Figure Other Picture

Table Major Manufacturers of Other

Table Applications of Mitomycin C

Figure Global Consumption Volume Market Share of Mitomycin C by Application in 2017

Figure Cancer Treatment Examples

Table Major Consumers in Cancer Treatment

Figure Ophthalmic Use Examples

Table Major Consumers in Ophthalmic Use

Figure Others Examples

Table Major Consumers in Others

Figure Market Share of Mitomycin C by Regions

Figure North America Mitomycin C Market Size (Million USD) (2013-2025)

Figure Europe Mitomycin C Market Size (Million USD) (2013-2025)

Figure China Mitomycin C Market Size (Million USD) (2013-2025)

Figure Japan Mitomycin C Market Size (Million USD) (2013-2025)

Figure Southeast Asia Mitomycin C Market Size (Million USD) (2013-2025)

Figure India Mitomycin C Market Size (Million USD) (2013-2025)

Table Mitomycin C Raw Material and Suppliers

Table Manufacturing Cost Structure Analysis of Mitomycin C in 2017

Figure Manufacturing Process Analysis of Mitomycin C

Figure Industry Chain Structure of Mitomycin C

Table Capacity and Commercial Production Date of Global Mitomycin C Major Manufacturers in 2017

Table Manufacturing Plants Distribution of Global Mitomycin C Major Manufacturers in 2017

Table R&D Status and Technology Source of Global Mitomycin C Major Manufacturers in 2017

Table Raw Materials Sources Analysis of Global Mitomycin C Major Manufacturers in 2017

Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Mitomycin C 2013-2018E

Figure Global 2013-2018E Mitomycin C Market Size (Volume) and Growth Rate

Figure Global 2013-2018E Mitomycin C Market Size (Value) and Growth Rate

Table 2013-2018E Global Mitomycin C Capacity and Growth Rate

Table 2017 Global Mitomycin C Capacity (K Units) List (Company Segment)

Table 2013-2018E Global Mitomycin C Sales (K Units) and Growth Rate

Table 2017 Global Mitomycin C Sales (K Units) List (Company Segment)

Table 2013-2018E Global Mitomycin C Sales Price (USD/Unit)

Table 2017 Global Mitomycin C Sales Price (USD/Unit) List (Company Segment)

Figure North America Capacity Overview

Table North America Supply, Import, Export and Consumption (K Units) of Mitomycin C 2013-2018E

Figure North America 2013-2018E Mitomycin C Sales Price (USD/Unit)

Figure North America 2017 Mitomycin C Sales Market Share

Figure Europe Capacity Overview

Table Europe Supply, Import, Export and Consumption (K Units) of Mitomycin C 2013-2018E

Figure Europe 2013-2018E Mitomycin C Sales Price (USD/Unit)

Figure Europe 2017 Mitomycin C Sales Market Share

Figure China Capacity Overview

Table China Supply, Import, Export and Consumption (K Units) of Mitomycin C 2013-2018E

Figure China 2013-2018E Mitomycin C Sales Price (USD/Unit)

Figure China 2017 Mitomycin C Sales Market Share

Figure Japan Capacity Overview

Table Japan Supply, Import, Export and Consumption (K Units) of Mitomycin C 2013-2018E

Figure Japan 2013-2018E Mitomycin C Sales Price (USD/Unit)

Figure Japan 2017 Mitomycin C Sales Market Share

Figure Southeast Asia Capacity Overview

Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Mitomycin C 2013-2018E

Figure Southeast Asia 2013-2018E Mitomycin C Sales Price (USD/Unit)

Figure Southeast Asia 2017 Mitomycin C Sales Market Share

Figure India Capacity Overview

Table India Supply, Import, Export and Consumption (K Units) of Mitomycin C 2013-2018E

Figure India 2013-2018E Mitomycin C Sales Price (USD/Unit)

Figure India 2017 Mitomycin C Sales Market Share

Table Global 2013-2018E Mitomycin C Sales (K Units) by Type

Table Different Types Mitomycin C Product Interview Price

Table Global 2013-2018E Mitomycin C Sales (K Units) by Application

Table Different Application Mitomycin C Product Interview Price

Table Kyowa-kirin Information List

Table Product Overview

Table 2017 Kyowa-kirin Mitomycin C Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)

Figure 2017 Kyowa-kirin Mitomycin C Business Region Distribution

Table Intas Pharmaceuticals Information List

Table Product Overview

Table 2017 Intas Pharmaceuticals Mitomycin C Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)

Figure 2017 Intas Pharmaceuticals Mitomycin C Business Region Distribution

Table Teva Information List

Table Product Overview

Table 2017 Teva Mitomycin C Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)

Figure 2017 Teva Mitomycin C Business Region Distribution

Table Bristol-Myers Squibb Information List

Table Product Overview

Table 2017 Bristol-Myers Squibb Mitomycin C Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)

Figure 2017 Bristol-Myers Squibb Mitomycin C Business Region Distribution

Table Aspen Information List

Table Product Overview

Table 2017 Aspen Mitomycin C Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)

Figure 2017 Aspen Mitomycin C Business Region Distribution

Table Speciality European Pharma Information List

Table Product Overview

Table 2017 Speciality European Pharma Mitomycin C Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)

Figure 2017 Speciality European Pharma Mitomycin C Business Region Distribution

Table Alkem Laboratories Information List

Table Product Overview

Table 2017 Alkem Laboratories Mitomycin C Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)

Figure 2017 Alkem Laboratories Mitomycin C Business Region Distribution

Table Varifarma Information List

Table Product Overview

Table 2017 Varifarma Mitomycin C Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)

Figure 2017 Varifarma Mitomycin C Business Region Distribution

Table APOGEPHA Information List

Table Product Overview

Table 2017 APOGEPHA Mitomycin C Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)

Figure 2017 APOGEPHA Mitomycin C Business Region Distribution

Figure Global 2018-2025 Mitomycin C Market Size (K Units) and Growth Rate Forecast

Figure Global 2018-2025 Mitomycin C Market Size (Million USD) and Growth Rate Forecast

Figure Global 2018-2025 Mitomycin C Sales Price (USD/Unit) Forecast

Figure North America 2018-2025 Mitomycin C Consumption Volume (K Units) and Growth Rate Forecast

Figure China 2018-2025 Mitomycin C Consumption Volume (K Units) and Growth Rate Forecast

Figure Europe 2018-2025 Mitomycin C Consumption Volume (K Units) and Growth Rate Forecast

Figure Southeast Asia 2018-2025 Mitomycin C Consumption Volume (K Units) and Growth Rate Forecast

Figure Japan 2018-2025 Mitomycin C Consumption Volume (K Units) and Growth Rate Forecast

Figure India 2018-2025 Mitomycin C Consumption Volume (K Units) and Growth Rate Forecast

Table Global Sales Volume (K Units) of Mitomycin C by Type 2018-2025

Table Global Consumption Volume (K Units) of Mitomycin C by Application 2018-2025

Table Traders or Distributors with Contact Information of Mitomycin C by Region

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370